Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Assets Average (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Assets Average over the past 9 years, most recently at $32.3 million for Q4 2023.

  • For Q4 2023, Assets Average fell 53.94% year-over-year to $32.3 million; the TTM value through Dec 2023 reached $32.3 million, down 53.94%, while the annual FY2023 figure was $47.3 million, 45.65% down from the prior year.
  • Assets Average for Q4 2023 was $32.3 million at Corbus Pharmaceuticals Holdings, down from $40.0 million in the prior quarter.
  • Over five years, Assets Average peaked at $130.4 million in Q2 2021 and troughed at $32.3 million in Q4 2023.
  • A 5-year average of $82.0 million and a median of $79.8 million in 2020 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: surged 112.02% in 2021 and later tumbled 53.94% in 2023.
  • Year by year, Assets Average stood at $58.6 million in 2019, then skyrocketed by 68.95% to $99.1 million in 2020, then increased by 14.72% to $113.7 million in 2021, then plummeted by 38.35% to $70.1 million in 2022, then tumbled by 53.94% to $32.3 million in 2023.
  • Business Quant data shows Assets Average for CRBP at $32.3 million in Q4 2023, $40.0 million in Q3 2023, and $47.7 million in Q2 2023.